China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
China Resources Pharmaceutical Group Ltd. has entered into new Procurement and Products and Commodities Sales Framework Agreements with CR Holdings, set to begin in January 2025 and last until the end of 2027. These agreements, which involve purchasing supplies and products, are classified as continuing connected transactions under Hong Kong’s Listing Rules. The transactions are subject to reporting and annual review requirements but do not require independent shareholders’ approval.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Amazon (NASDAQ:AMZN) Carries on With Grocery Store Plans
- Ford (NYSE:F) Faces Multiple Product Recalls
- ‘Favorable Trends,’ Says Top Investor About Super Micro Computer Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
